LSCC vs NVDA

LSCC exhibits a strong deterministic health profile with a Piotroski F-Score of 8/9, indicating robust operational efficiency and financial stability. However, this fundamental strength is starkly contrasted by an extreme valuation disconnect, evidenced by a trailing P/E of 5388 and a Graham Number of $1.53. While revenue growth remains healthy at 24.2%, recent earnings performance has deteriorated significantly with a -39.63% average surprise over the last four quarters. The stock is currently trading at a massive premium based on future growth expectations rather than current profitability.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.